Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations
The Lancet Neurology, 07/05/2012
Galpern WR et al. – Throughout the clinical development process, the perspectives of researchers, ethicists, and patients must be considered, and risks should be minimised whenever possible in a manner that is consistent with good trial design.



